Comparative Pharmacology
Head-to-head clinical analysis: ACTICORT versus HYDROCORTISONE ACETATE 1 AND PRAMOXINE HYDROCHLORIDE 1.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ACTICORT versus HYDROCORTISONE ACETATE 1 AND PRAMOXINE HYDROCHLORIDE 1.
ACTICORT vs HYDROCORTISONE ACETATE 1% AND PRAMOXINE HYDROCHLORIDE 1%
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Topical corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive actions. Suppresses cytokine production and inflammatory mediators via glucocorticoid receptor binding.
Hydrocortisone acetate is a corticosteroid that binds to glucocorticoid receptors, modulating gene expression to reduce inflammation, vasodilation, and immune cell activity. Pramoxine hydrochloride is a local anesthetic that reversibly blocks sodium ion channels in nerve cell membranes, inhibiting nerve impulse conduction and providing topical anesthesia.
5-60 mg orally once daily, or divided twice daily, depending on condition severity and response.
Apply a thin film to affected area three to four times daily. Topical only.
None Documented
None Documented
1.5-2.5 hours; prolonged in hepatic impairment (up to 10 hours) and renal impairment (up to 6 hours)
Hydrocortisone acetate: 1.5–2 hours (plasma), clinically adrenocortical suppression lasts 24–48 hours; pramoxine: not applicable due to minimal absorption.
Renal (70% as unchanged drug and metabolites), biliary/fecal (30%)
Hydrocortisone acetate: primarily renal (about 90% as metabolites, less than 1% unchanged); pramoxine HCl: negligible systemic absorption, eliminated primarily via fecal excretion.
Category C
Category D/X
Corticosteroid
Corticosteroid